Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Nov 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of anticoagulant treatments (medications that help prevent blood clots) in patients with venous thromboembolism, which is a condition that involves blood clots in the veins. Specifically, the researchers want to find out how often patients experience complications, like blood clots or bleeding, while being treated with either low molecular weight heparin or direct oral anticoagulants. The study is taking place at two hospitals in Italy and is looking at both past and current patient data from January 2016 to June 2027.

To be eligible for this trial, participants must be at least 18 years old and have been diagnosed with a blood clot, either in a vein or in the lungs. They should also have a solid or blood cancer that is currently being treated or is active. Participants will be treated based on their doctor's recommendations, and the study aims to gather valuable information without changing their usual care. If you or a family member meet these criteria, you may have the opportunity to contribute to important research that could improve treatment for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Diagnosis of venous thrombosis at any site
• • Diagnosis of CVC-related venous thrombosis
• • Diagnosis of pulmonary embolism, both symptomatic and incidental
• • Diagnosis of solid or hematological neoplasm, either under treatment or active
• • Obtaining of Informed Consent
• Exclusion Criteria:
• • None